Categories: News

4 Ways Anesthesia Shifted in The Age of Covid-19

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Full Article Published in OR Today by Steven Eror, CEO of Solo-Dex

WOLF CREEK, MT / ACCESSWIRE / July 15, 2021 / There are four important trends in anesthesia that emerged from the Covid pandemic. His article, “Leading-Edge Anesthesia in the Post Covid Era,” appears in full at ORToday.com

In the article, Mr. Eror observes:

  • Continuous Regional Anesthesia Reduces the Risk of Patient and Operating Staff Infection
  • Continuous Regional Anesthesia Reduces Risk of Oral Opioid Abuse
  • Regional Anesthesia Offers Scheduling Advantages
  • Regional Anesthesia has Innovated to Overcome Technical Challenges

Mr. Eror states, “The awareness that regional anesthesia has innovated surgical and recovery pain management became evident to patients, providers, and payors during the crisis of the pandemic. The lessons learned will support the opportunity to improve the way we provide care.”

He concludes that the use of continuous regional anesthesia is expanding rapidly. Clinicians have developed a much greater appreciation of its ability to manage pain for safer more pleasant surgery and faster recovery. As a company focused upon bringing continuous regional anesthesia into broader use and into the home, Solo-Dex is well-positioned to benefit from these trends.

The Montana High Tech Business Alliance put Solo-Dex on its 2020 list of Montana Companies to Watch, one of 11 firms so honored.

About OR Today

For nearly 20 years, OR Today has provided perioperative and SPD professionals with up-to-date news and information about their profession. The magazine aims to educate readers about new guidelines, techniques, and equipment, as well as practical information for career building, problem-solving and overall well-being.

ABOUT SOLO-DEX

Solo-Dex is a developer and distributor of medical catheters, founded by leading anesthesiologists to reduce the cost and risk associated with general anesthesia by improving surgical patient recovery times, reducing medical personnel exposure to Covid-19, reducing or eliminating the misuse of opioid-related pain management, and by safely and effectively managing pain before, during and after a procedure. For more information about SOLO-DEX, please log on to www.solo-dex.com

Media Contact:
Janet Vasquez, Public Relations
Solo-Dex Inc.
pr@solo-dex.com

SOURCE: Solo-Dex Inc.

View source version on accesswire.com:
https://www.accesswire.com/655532/4-Ways-Anesthesia-Shifted-in-The-Age-of-Covid-19

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

6 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

6 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

9 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

9 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

9 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

9 hours ago